Mitsubishi Chemical Group has revised its SoarnoL investment plan in the UK due to rising construction costs, inflation and project delays.
The capacity expansion faces higher expenses, impacting profitability.
MCG expects a ¥30 billion (~$205 million) impairment loss for FY2026, while the new facility is now set to begin operations in FY2027.